DCGI Firmly Confirms Bold Commitment to Drug Safety, Clarifies Misinterpretations on Spurious Labels
DCGI Clarifies Misunderstanding Over Spurious Drug Labels DCGI, in a recent statement, addressed concerns regarding the labeling of certain drugs…
DCGI Clarifies Misunderstanding Over Spurious Drug Labels DCGI, in a recent statement, addressed concerns regarding the labeling of certain drugs…
Venus Remedies Secures Market Authorisations for Two Cancer Drugs in Morocco and the Philippines Venus Remedies, a leading pharmaceutical company…
Glaxo Smith Kline plc (LSE/NYSE: GSK) has announced its disagreement with a recent ruling by the Delaware State Court in…